Evidence map›Paper›PMID 32471263›Full record

ArticleInternational journal of molecular sciences2020

Improvement of Impaired Motor Functions by Human Dental Exfoliated Deciduous Teeth Stem Cell-Derived Factors in a Rat Model of Parkinson's Disease.

Yong-Ren Chen, Pei-Lun Lai, Yueh Chien, Po-Hui Lee, Ying-Hsiu Lai, Hsin-I Ma, Chia-Yang Shiau, Kuo-Chuan Wang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Yong-Ren ChenDivision of Neurosurgery, Department of surgery, National Taiwan University Hospital, Taipei 100, Taiwan.
Pei-Lun LaiGenomics Research Center, Academia Sinica, Taipei 11529, Taiwan.
Yueh ChienCancer Progression Research Center, National Yang-Ming University, Taipei 11221, Taiwan.
Po-Hui LeeNon-invasive Cancer Therapy Research Institute - Taiwan, Taipei 104, Taiwan.
Ying-Hsiu LaiDepartment of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Hsin-I MaDepartment of Neurosurgery, Tri-Service General Hospital, Taipei 115, Taiwan.
Chia-Yang ShiauGraduate Institute of Medical Sciences, National Defense Medical Center, Taipei 114, Taiwan.
Kuo-Chuan WangDivision of Neurosurgery, Department of surgery, National Taiwan University Hospital, Taipei 100, Taiwan.
National Taiwan University Hospital · TWGenomics Research Center, Academia Sinica · TWNational Defense Medical Center · TWNational Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWTri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a long-term degenerative disease of the central nervous system (CNS) that primarily affects the motor system. So far there is no effective treatment for PD, only some drugs, surgery, and comprehensive treatment can alleviate the symptoms of PD. Stem cells derived from human exfoliated deciduous teeth (SHED), mesenchymal stem cells derived from dental pulp, may have promising potential in regenerative medicine. In this study, we examine the therapeutic effect of SHED-derived conditioned medium (SHED-CM) in a rotenone-induced PD rat model. Intravenous administration of SHED-CM generated by standardized procedures significantly improved the PD symptoms accompanied with increased tyrosine hydroxylase amounts in the striatum, and decreased α-synuclein levels in both the nigra and striatum, from rotenone-treated rats. In addition, this SHED-CM treatment decreased both Iba-1 and CD4 levels in these brain areas. Gene ontology analysis indicated that the biological process of genes affected by SHED-CM was primarily implicated in neurodevelopment and nerve regeneration. The major constituents of SHED-CM included insulin-like growth factor binding protein-6 (IGFBP-6), tissue inhibitor of metalloproteinase (TIMP)-2, TIMP-1, and transforming growth factor 1 (TGF-1). RNA-sequencing (RNA-seq) and Ingenuity Pathway Analysis (IPA) revealed that these factors may ameliorate PD symptoms through modulating the cholinergic synapses, calcium signaling pathways, serotoninergic synapses, and axon guidance. In conclusion, our data indicate that SHED-CM contains active constituents that may have promising efficacy to alleviate PD.

Indexed as

alpha-SynucleinAnimalsCells, CulturedCorpus StriatumCulture Media, ConditionedFemaleHumansInjections, IntravenousInsulin-Like Growth Factor Binding Protein 6Mesenchymal Stem CellsNeuroprotective AgentsParkinson DiseaseRatsRats, Inbred LewTissue Inhibitor of MetalloproteinasesTooth, Deciduousalpha-SynucleinCulture Media, ConditionedInsulin-Like Growth Factor Binding Protein 6Neuroprotective AgentsTissue Inhibitor of MetalloproteinasesTransforming Growth Factor betaTyrosine 3-Monooxygenasehuman exfoliated deciduous teeth, stem cell, Parkinson's disease (PD), rotenone

Identifiers

PMID32471263
PMCPMC7312764
OpenAlexW3032881090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.